Raymond James analyst Ric Prentiss downgrades Radius Global Infr (NASDAQ:RADI) from Strong Buy to Underperform.
Raymond James Downgrades Radius Global Infr to Underperform
Raymond James analyst Ric Prentiss downgrades Radius Global Infr (NASDAQ:RADI) from Strong Buy to Underperform.
Related Posts
FDA Approves Treatment Of Amyotrophic Lateral Sclerosis Associated With A Mutation In The SOD1 Gene
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated
Story Cannabis Company To Acquire 4 Vertically Integrated Nature’s Medicines Dispensaries In Phoenix
Story Cannabis Company, an emerging player in the fast-growing cannabis industry, announced the acquisition of four vertically integrated cannabis licenses, currently branded under the name Nature’s Medicines, located in Arizona.
